Approval · Notice of Compliance 10445 · 2009
MABCAMPATH: Notice of Compliance 10445
Issued July 27, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10445
- Date
- July 27, 2009
- Company
- Genzyme Canada Inc
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MABCAMPATH | 02290960 | Marketed |
Medicinal ingredients
- ALEMTUZUMAB 30 MG per ML